Poellath advised Synlab’s board of directors on the deal. Clifford Chance has advised SYNLAB, Europe’s leading medical laboratory and diagnostic services company, and its majority shareholders…
Poellath advised Synlab’s board of directors on the deal. Clifford Chance has advised SYNLAB, Europe’s leading medical laboratory and diagnostic services company, and its majority shareholders…
You must be a Standard 1 Year member to access this content.
…
You must be a Standard 1 Year member to access this content.